Evidence map›Paper›PMID 38805054›Full record

ArticleJournal of neurology2024

Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease.

Emily Beswick, Alexander Christides, Alexander Symonds, Micheaela Johnson, Thomas Fawcett, Judith Newton, Dawn Lyle, Christine Weaver, Siddharthan Chandran, Suvankar Pal

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emily BeswickCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.ORCID http://orcid.org/0000-0001-9843-0778
Alexander ChristidesCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.ORCID http://orcid.org/0000-0002-9476-9827
Alexander SymondsCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Micheaela JohnsonCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Thomas FawcettThe School of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, Scotland.
Judith NewtonCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Dawn LyleCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Christine WeaverCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Siddharthan ChandranCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Suvankar PalCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland. suvankar.pal@ed.ac.uk.ORCID http://orcid.org/0000-0003-4276-639X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motor neuron disease (MND) is a rapidly progressive condition traditionally assessed using a questionnaire to evaluate physical function, the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R). Its use can be associated with poor sensitivity in detecting subtle changes over time and there is an urgent need for more sensitive and specific outcome measures. The ActiGraph GT9X is a wearable device containing multiple sensors that can be used to provide metrics that represent physical activity. The primary aim of this study was to investigate the initial suitability and acceptability of limb-worn wearable devices to group of people with MND in Scotland. A secondary aim was to explore the preliminary associations between the accelerometer sensor data within the ActiGraph GT9X and established measures of physical function. 10 participants with MND completed a 12-week schedule of assessments including fortnightly study visits, both in-person and over videoconferencing software. Participants wore the device on their right wrist and right ankle for a series of movements, during a 6-min walking test and for a period of 24-h wear, including overnight. Participants also completed an ALSFRS-R and questionnaires on their experience with the devices. 80% of the participants found wearing these devices to be a positive experience and no one reported interference with daily living or added burden. However, 30% of the participants experienced technical issues with their devices. Data from the wearable devices correlated with established measures of physical function.

Indexed as

AccelerometryDisease ProgressionMotor Neuron DiseaseWearable Electronic DevicesAgedFemaleHumansMaleMiddle AgedPatient Acceptance of Health CareSurveys and QuestionnairesAccelerometerDigital healthMotor neuron diseaseWearable devices

Identifiers

PMID38805054
PMCPMC11319372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.